Connexin43 Hemichannel Blockade Turns Microglia Neuroprotective and Mitigates Cognitive Deficits in a Mouse Model of Amyloidosis

Researchers identified microglial connexin43 hemichannels as a regulator of microglial reactivity in Alzheimer’s disease, positioning them as a promising therapeutic target.